NVIC

High-Dose Flu Vaccines

Published August 23, 2024

The high-dose influenza vaccine, Fluzone, is approved for adults age 65 and older and contains four times the amount of antigen than the standard flu vaccine.  This vaccine was given a preferential recommendation by the CDC in 2022 for use in persons 65 years of age and older.  This vaccine is designed to hyper-stimulate the immune system to produce a stronger antibody response in the elderly.  High-dose Fluzone is the only high-dose flu vaccine currently available in the U.S. 

Select disease / vaccine